MyFinsight
Home
Blog
About
Contact
Download
Download image
In-process research and
development
$420,000K
Finite-lived intangible
assets, net
$499,925K
Prepaid expenses and
other current assets
$126,284K
Inventory
$166,201K
Accounts receivable, net
$298,653K
Marketable securities
$8,715K
Cash and cash
equivalents
$955,996K
Other long-term
assets, net
$185,811K
Intangible assets, net
$919,925K
Goodwill
$2,368,048K
Operating lease
right-of-use assets
$122,332K
Property, plant and
equipment, net
$708,664K
Total current assets
$1,555,849K
Total assets
$5,860,629K
Total liabilities and
stockholders equity
$5,860,629K
Total stockholders
equity
$2,401,052K
Total liabilities
$3,459,577K
Accumulated deficit
-$4,705,981K
Accumulated other
comprehensive income (loss)
$2,358K
Additional paid-in capital
$7,102,766K
Operating lease
liabilities, less current...
$161,931K
Other long-term
liabilities
$329,317K
Convertible notes, net, less
current portion
$2,327,177K
Total current
liabilities
$641,152K
Common stock, 0.01 par
value...
$1,909K
Other current
liabilities
$15,220K
Operating lease
liabilities, current portion
$33,591K
Accrued liabilities
$416,473K
Accounts payable
$175,868K
Back
Back
Balance Sheet
source: myfinsight.com
EXACT SCIENCES CORP (EXAS)
EXACT SCIENCES CORP (EXAS)